A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TAD / tadalafil

[Related PubMed/MEDLINE]
Total Number of Papers: 42
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TAD  (>> Co-occurring Abbreviation)
Long Form:   tadalafil
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line. AR, BCT, ERbeta, PCa
2021 Tadalafil Alleviates LPS-Induced Inflammation and Oxidative Stress of RWPE-1 Cell by Regulating the Akt/Nrf2 Signaling Pathway. CAT, CNP, MDA
2021 Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways. BG, PP2A, SAD, STZ
2020 A Validated Green HPTLC Method for Quantitative Determination of Dapoxetine Hydrochloride and Tadalafil in Bulk and Pharmaceutical Formulations. DAP, HPTLC
2020 Ultraviolet cutoff area and predictive ability of partial least squares regression method: A pharmaceutical case study. COA, DAP
2019 Evaluation of the solid state form of tadalafil in sub-micron thin films using nanomechanical infrared spectroscopy. ATR-FTIR, NAM-IR, RH
2019 Linear Support Vector Regression and Partial Least-Squares for Determination of Dapoxetine Hydrochloride and Tadalafil in Binary Pharmaceutical Mixtures. DAP, PLS, SVR
2019 Quantitative determination of Dapoxetine Hydrochloride and Tadalafil using different validated spectrophotometric methods. AUC, DAP, EXRS
2018 Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study. DAC, IS, SOF
10  2018 Effects on sexual function in Japanese patients with benign prostatic hyperplasia upon switching from combination therapy with α1 blocker and dutasteride to combination therapy with tadalafil and dutasteride. BMI, BPH, DUT, EHS, IPSS, OABSS
11  2018 Hepatic safety of ambrisentan alone and in combination with tadalafil: a post-hoc analysis of the AMBITION trial. ABS, BCT, ERA, PAH, PDE5, TBILI
12  2018 Quantitation of tadalafil in human plasma using a sensitive and rapid LC-MS/MS method for a bioequivalence study. IS
13  2017 Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles. FPF, MMAD, NPs, PLGA, PVA
14  2017 PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice. HCQ, I/R, IGF-1, mTOR
15  2017 Pt nanoparticles supported on nitrogen-doped porous graphene for sensitive detection of Tadalafil. Gr, NPGR, PtNPs
16  2017 Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization. ED, LUTS
17  2016 alpha1A-Adrenergic Receptor Antagonism Improves Erectile and Cavernosal Responses in Rats With Cavernous Nerve Injury and Enhances Neurogenic Responses in Human Corpus Cavernosum From Patients WithErectile Dysfunction Secondary to Radical Prostatectomy. BCNI, CC, CNI, ED, RP, SILOD
18  2016 Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats. BCNI, CC, CNI
19  2016 Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study. ED, IPSS, OAB, T/E
20  2016 Effects of tadalafil treatment combined with physical activity in patients with low onset hypogonadism: results from a not-randomized single arm phase 2 study. LOH, PA, PDUE
21  2015 A novel liquid chromatographic method with fluorescence detection for quantitation of tadalafil and dapoxetine hydrochloride in pharmaceutical dosage form and human plasma. DAP, ICH, IS
22  2015 Cardioprotective role of tadalafil against cisplatin-induced cardiovascular damage in rats. alpha-SMA, cTnI, i.p, MDA, NO
23  2015 Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury. cGMP, CON, I/R, iNO, LV, MI, PDE5, TnI
24  2015 Involvement of NO-cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia. cGMP, i.p, NO, p.o, PDE5, PWLs
25  2015 Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model. AR, ARO, ER, PDE5i
26  2015 Validated spectrofluorimetric method for determination of two phosphodiesterase inhibitors tadalafil and vardenafil in pharmaceutical preparations and spiked human plasma. LOD, LOQ, VAR
27  2014 Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil. ED, IIEF, IIEF-EF, OAD, PBO, PDE5-Is, SEP, SIL, VAR
28  2014 Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition. AMB, ERAs, PAH, PAP, PDE5, RV
29  2014 Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride. AEs, BPH, ED, FIN, IIEF, IIEF-EF, LUTS, MCIDs, PBO
30  2013 Effects of tadalafil on ischemia/reperfusion injury in rat brain. I/R, ROS
31  2013 Profiling counterfeit Cialis, Viagra and analogs by UPLC-MS. APIs, DAD, MS, QTOF, SLD, UPLC
32  2013 Seminal vesicles and diabetic neuropathy: ultrasound evaluation after prolonged treatment with a selective phosphodiesterase-5 inhibitor. APD, DM, DN, F/B, SV
33  2013 Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytes. ATP, cAMP, IPR, PAH, PDE3, PDE5, ZAP
34  2012 Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice. NO
35  2012 Seminal vesicles of infertile patients with male accessory gland infection: ultrasound evaluation after prolonged treatment with tadalafil, a selective phosphodiesterase-5 inhibitor. MAGI, SV
36  2010 Determination of tadalafil in pure powder and tablet dosage form by high-performance liquid chromatography. ---
37  2009 Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. ACh, BCN, ED, eNOS, nNOS, PDE5, qRT-PCR, RRP, SNP
38  2007 Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with erectile dysfunction and coronary artery disease. CAD, DpH, ED, IIEF
39  2007 [PDE5 inhibitors. A new option in the treatment of ureteral colic?]. ED, SIL, VAR
40  2006 In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach. BSC, NO, PDE, SIL, SNP, VAR
41  2005 Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. ED, FMD, PDE5, PLB
42  2004 Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. ED, FT, Sild, TT